The London Biotech Show 2026 is Europe’s leading platform for the biotechnology industry, showcasing the full spectrum of red biotech including biopharmaceuticals, therapeutics, gene and cell therapy, regenerative medicine, diagnostics, precision medicine, vaccines, clinical trials, and biomanufacturing.
The event will bring together biotech companies, pharmaceutical leaders, medtech innovators, investors, researchers, policymakers, and solution providers from across the globe to exchange knowledge, forge partnerships, and accelerate innovation.
Through its world-class exhibition, high-level conference, and the Global Biotech Awards, the show enables attendees to explore cutting-edge technologies, secure investments, expand into new markets, and drive the next wave of breakthroughs in healthcare and life sciences.
Featuring a comprehensive conference agenda, the event will host a broad spectrum of top-notch speaker keynotes & panel discussions focusing on the latest developments in the red biotechnology vertical. The conference will provide an apt platform for global thought leaders, decision-makers and industry pioneers to share deep industry insights, exchange key ideas.
The exhibition at #LBS26 offers a premier platform for leading biotech players and emerging ventures to showcase cutting-edge innovations shaping healthcare, life sciences, and beyond, connecting directly with an international community of stakeholders.